Clozapine in schizophrenia and its association with treatment satisfaction and quality of life: Findings of the three national surveys on use of psychotropic medications in China (2002-2012)

Q. Li, Y.T. Xiang, Y.A. Su, L. Shu, X. Yu, C.U. Correll, Gabor Ungvari, H.F.K. Chiu, C. Ma, G.H. Wang, P.S. Bai, T. Li, L.Z. Sun, J.G. Shi, X.S. Chen, Q.Y. Mei, K.Q. Li, T.M. Si, J.M. Kane

    Research output: Contribution to journalArticle

    5 Citations (Scopus)

    Abstract

    © 2015 Elsevier B.V. Objective: We examined the time trends and correlates of clozapine use in schizophrenia patients in China. Method: A total of 14,013 patients with schizophrenia treated in 45 psychiatric hospitals/centers nationwide were interviewed in 2002, 2006 and 2012. Patients' socio-demographic and clinical characteristics including psychopathology, medication side effects, satisfaction with treatment and quality of life (QOL) were recorded in a standardized fashion. Results: Clozapine was used in 32.9% of the whole sample; with corresponding figures of 39.7%, 32.5% and 26.4% in 2002, 2006 and 2012 (p2=0.498, p
    Original languageEnglish
    Pages (from-to)523-529
    JournalSchizophrenia Research
    Volume168
    Issue number1-2
    DOIs
    Publication statusPublished - 2015

    Fingerprint

    Clozapine
    China
    Schizophrenia
    Quality of Life
    Psychiatric Hospitals
    Psychopathology
    Therapeutics
    Demography
    Surveys and Questionnaires

    Cite this

    Li, Q. ; Xiang, Y.T. ; Su, Y.A. ; Shu, L. ; Yu, X. ; Correll, C.U. ; Ungvari, Gabor ; Chiu, H.F.K. ; Ma, C. ; Wang, G.H. ; Bai, P.S. ; Li, T. ; Sun, L.Z. ; Shi, J.G. ; Chen, X.S. ; Mei, Q.Y. ; Li, K.Q. ; Si, T.M. ; Kane, J.M. / Clozapine in schizophrenia and its association with treatment satisfaction and quality of life: Findings of the three national surveys on use of psychotropic medications in China (2002-2012). In: Schizophrenia Research. 2015 ; Vol. 168, No. 1-2. pp. 523-529.
    @article{d212e46dcccf4380a043d119420ac2c8,
    title = "Clozapine in schizophrenia and its association with treatment satisfaction and quality of life: Findings of the three national surveys on use of psychotropic medications in China (2002-2012)",
    abstract = "{\circledC} 2015 Elsevier B.V. Objective: We examined the time trends and correlates of clozapine use in schizophrenia patients in China. Method: A total of 14,013 patients with schizophrenia treated in 45 psychiatric hospitals/centers nationwide were interviewed in 2002, 2006 and 2012. Patients' socio-demographic and clinical characteristics including psychopathology, medication side effects, satisfaction with treatment and quality of life (QOL) were recorded in a standardized fashion. Results: Clozapine was used in 32.9{\%} of the whole sample; with corresponding figures of 39.7{\%}, 32.5{\%} and 26.4{\%} in 2002, 2006 and 2012 (p2=0.498, p",
    author = "Q. Li and Y.T. Xiang and Y.A. Su and L. Shu and X. Yu and C.U. Correll and Gabor Ungvari and H.F.K. Chiu and C. Ma and G.H. Wang and P.S. Bai and T. Li and L.Z. Sun and J.G. Shi and X.S. Chen and Q.Y. Mei and K.Q. Li and T.M. Si and J.M. Kane",
    year = "2015",
    doi = "10.1016/j.schres.2015.07.048",
    language = "English",
    volume = "168",
    pages = "523--529",
    journal = "Schizophrenia Research",
    issn = "0920-9964",
    publisher = "Pergamon",
    number = "1-2",

    }

    Li, Q, Xiang, YT, Su, YA, Shu, L, Yu, X, Correll, CU, Ungvari, G, Chiu, HFK, Ma, C, Wang, GH, Bai, PS, Li, T, Sun, LZ, Shi, JG, Chen, XS, Mei, QY, Li, KQ, Si, TM & Kane, JM 2015, 'Clozapine in schizophrenia and its association with treatment satisfaction and quality of life: Findings of the three national surveys on use of psychotropic medications in China (2002-2012)' Schizophrenia Research, vol. 168, no. 1-2, pp. 523-529. https://doi.org/10.1016/j.schres.2015.07.048

    Clozapine in schizophrenia and its association with treatment satisfaction and quality of life: Findings of the three national surveys on use of psychotropic medications in China (2002-2012). / Li, Q.; Xiang, Y.T.; Su, Y.A.; Shu, L.; Yu, X.; Correll, C.U.; Ungvari, Gabor; Chiu, H.F.K.; Ma, C.; Wang, G.H.; Bai, P.S.; Li, T.; Sun, L.Z.; Shi, J.G.; Chen, X.S.; Mei, Q.Y.; Li, K.Q.; Si, T.M.; Kane, J.M.

    In: Schizophrenia Research, Vol. 168, No. 1-2, 2015, p. 523-529.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Clozapine in schizophrenia and its association with treatment satisfaction and quality of life: Findings of the three national surveys on use of psychotropic medications in China (2002-2012)

    AU - Li, Q.

    AU - Xiang, Y.T.

    AU - Su, Y.A.

    AU - Shu, L.

    AU - Yu, X.

    AU - Correll, C.U.

    AU - Ungvari, Gabor

    AU - Chiu, H.F.K.

    AU - Ma, C.

    AU - Wang, G.H.

    AU - Bai, P.S.

    AU - Li, T.

    AU - Sun, L.Z.

    AU - Shi, J.G.

    AU - Chen, X.S.

    AU - Mei, Q.Y.

    AU - Li, K.Q.

    AU - Si, T.M.

    AU - Kane, J.M.

    PY - 2015

    Y1 - 2015

    N2 - © 2015 Elsevier B.V. Objective: We examined the time trends and correlates of clozapine use in schizophrenia patients in China. Method: A total of 14,013 patients with schizophrenia treated in 45 psychiatric hospitals/centers nationwide were interviewed in 2002, 2006 and 2012. Patients' socio-demographic and clinical characteristics including psychopathology, medication side effects, satisfaction with treatment and quality of life (QOL) were recorded in a standardized fashion. Results: Clozapine was used in 32.9% of the whole sample; with corresponding figures of 39.7%, 32.5% and 26.4% in 2002, 2006 and 2012 (p2=0.498, p

    AB - © 2015 Elsevier B.V. Objective: We examined the time trends and correlates of clozapine use in schizophrenia patients in China. Method: A total of 14,013 patients with schizophrenia treated in 45 psychiatric hospitals/centers nationwide were interviewed in 2002, 2006 and 2012. Patients' socio-demographic and clinical characteristics including psychopathology, medication side effects, satisfaction with treatment and quality of life (QOL) were recorded in a standardized fashion. Results: Clozapine was used in 32.9% of the whole sample; with corresponding figures of 39.7%, 32.5% and 26.4% in 2002, 2006 and 2012 (p2=0.498, p

    U2 - 10.1016/j.schres.2015.07.048

    DO - 10.1016/j.schres.2015.07.048

    M3 - Article

    VL - 168

    SP - 523

    EP - 529

    JO - Schizophrenia Research

    JF - Schizophrenia Research

    SN - 0920-9964

    IS - 1-2

    ER -